Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.09.2216
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Budget Impact Analysis of the Fentanyl Buccal Tablet for Treatment of Breakthrough Cancer Pain

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2013English

Intranasal Fentanyl for Breakthrough Pain Control

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2012English

Role of Intranasal Fentanyl in Breakthrough Pain Management in Cancer Patients

Cancer Management and Research
Oncology
2010English

A New Fast-Acting Sublingual Fentanyl (Recivit®) for Treating Breakthrough Cancer Pain

European Oncology and Haematology
OncologyHematology
2014English

Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2013English

Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2013English

Cn8 - Cost-Effectiveness Analysis of Oral Cancer Screening in Taiwan: A Real World Data Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Canadian Recommendations for the Management of Breakthrough Cancer Pain

Current Oncology
Oncology
2016English

Response to Oral Immediate‐Release Opioids for Breakthrough Pain in Patients With Advanced Cancer With Adequately Controlled Background Pain

Oncologist
Cancer ResearchMedicineOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy